 |
|
|
REFERENCES
1.
Pardridge WM: Brain metabolism: A perspective
from the blood-brain barrier. Physiol Rev 63:1481, 1983.
2.
Shaw JHF, Galler L, Holdaway IM, et al: The effect
of extradural blockage upon glucose and urea kinetics in surgical patients. Surg
Gynecol Obstet 165:260, 1987.
3.
Biebuyck JF: Effects of anesthetic agents on metabolic
pathways: Fuel utilization and supply during anesthesia. Br J Anaesth 45:263, 1973.
4.
Randle PJ: Regulatory interactions between lipids
and carbohydrates: The glucose fatty acid cycle after 35 years. Diabetes Metab
Rev 14:263, 1998.
5.
Sugden MC, Holness MJ, Palmer TN: Fuel selection
and carbon flux during the starved-to-fed transition. Biochem J 263:313, 1989.
6.
Wu P, Inskeep K, Bowker-Kinley MM, et al: Mechanism
responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in
starvation and diabetes. Diabetes 48:1593, 1994.
7.
Ruderman N, Berger M: The formation of glutamine
and alanine in skeletal muscle. J Biol Chem 249:5500, 1974.
8.
Felig P, Wahran J, Raf L: Evidence of inter-organ
amino acid transport by blood cells in humans. Proc Natl Acad Sci U S A 70:1775,
1973.
9.
Haymond MW, Miles JM: Branched chain amino acids
as a major source of alanine nitrogen in man. Diabetes 31:86, 1982.
10.
Robert JJ, Bier DM, Zhao XH, et al: Glucose and
insulin effects on de novo amino acid synthesis in young men. Metabolism 31:1210,
1982.
11.
Daughaday WH, Hall K, Raben MS, et al: Somatomedin:
Proposed designation for sulfation factor. Nature 235:107, 1972.
12.
Vary TC, Siegel JH: Sepsis, abnormal metabolic
control and multiple organ failure syndrome. In
Siegel JH (ed): Trauma: Emergency Surgery and Critical Care. New York, Churchill
Livingstone, 1987, p 411.
13.
Bone RC, Balk RA, Cerra FB, et al: Definitions
for sepsis and organ failure and guidelines for the use of innovative therapies in
sepsis. Chest 101:1644, 1992.
14.
Furlan AJ, Hanson M, Cooperman A: Acute areflexic
paralysis associated with hyperalimentation and hypophosphatemia. Arch Neurol 32:696,
1975.
15.
Askanazi J, Weissman C, LaSala PA, et al: Effect
of protein intake on ventilatory drive. Anesthesiology 60:106, 1984.
16.
Sieber FE, Smith DS, Traystman RJ, et al: Glucose:
A reevaluation of its intraoperative use. Anesthesiology 67:72, 1987.
17.
Seki S: Clinical features of hyperosmolar hyperglycemic
nonketotic diabetic coma associated with cardiac operation. J Thorac Cardiovasc
Surg 91:867, 1986.
18.
Wolfe RR: Regulation of glucose metabolism. In
Burke JF (ed): Surgical Physiology. Philadelphia, WB Saunders, 1983, p 75.
19.
Wolfe RR, Allsop JR, Burke JF: Glucose metabolism
in man: Response to intravenous glucose infusion. Metabolism 28:210, 1979.
20.
Nordenstrom J, Persson E: Energy supply during
total parenteral nutrition: How much and what source. Acta Anesthesiol Scand 29:95,
1985.
21.
Wolfe RR, Burke JF: Glucose and lactate metabolism
in experimental septic shock. Am J Physiol 235:R219, 1978.
22.
Burke JF, Wolfe RR, Mullany C, et al: Glucose
requirements following burn injury. Ann Surg 190:274, 1979.
23.
Shangraw RE, Jahoor F, Miyoshi H, et al: Differentiation
between septic and post-burn insulin resistance. Metabolism 38:983, 1989.
24.
Van den Berghe G, Wouters P, Weekers F, et al:
Intensive insulin therapy in critically-ill patients. N Engl J Med 345:1359, 2001.
25.
Van den Berghe G, Wouters PJ, Bouillon R, et al:
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose
versus glycemic control. Crit Care Med 31:359, 2003.
26.
Baue AE: Multiple progressive, or sequential organ
systems failure. Arch Surg 110:779, 1975.
27.
Carrico CJ, Meakins JL, Marshall JC, et al: Multiple
organ failure syndrome. Arch Surg 121:196, 1986.
28.
Fry DE, Pearlstein L, Fulton RL, et al: Multiple
system organ failure: The role of uncontrolled infection. Arch Surg 115:136, 1980.
29.
Cerra FB: Hypermetabolism-organ failure: A metabolic
response to injury. Crit Care Clin 5:289, 1989.
30.
Cerra FB, Siegel JH, Coleman B, et al: Septic
autocatabolism: A failure of exogenous nutritional support. Ann Surg 192:570, 1980.
31.
Shaw JHF, Klein S, Wolfe RR: Assessment of alanine,
urea and glucose interrelationships in normal subjects and subjects with sepsis with
stable isotopes. Surgery 97:557, 1985.
32.
Lang CH, Bagby GJ, Spitzer JJ: Glucose kinetics
and body temperature after lethal and non-lethal doses of endotoxin. Am J Physiol
248:R471, 1985.
33.
Keller DL, Puinno PA, Fang BC, et al: Glucose
and lactate kinetics in septic rats. Metabolism 31:252, 1982.
34.
Wolfe RR, Burke JF: Glucose and lactate metabolism
in experimental septic shock. Am J Physiol 235:R219, 1978.
35.
Meszaros K, Bagby GJ, Lang CH, et al: Increased
uptake and phosphorylation of 2-deoxyglucose by skeletal muscle in endotoxin-treated
rats. Am J Physiol 253:E33, 1987.
36.
Lee MD, Zentella A, Pekala PH, et al: Effect of
endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. Proc
Natl Acad Sci U S A 84:2590, 1987.
37.
Lang CH, Dobrescu C, Meszaros K: Insulin-mediated
glucose uptake by individual tissues during sepsis. Metabolism 39:1096, 1990.
38.
Vary TC, Drnevich D, Brennan WA Jr: Mechanisms
regulating skeletal muscle glucose metabolism in sepsis. Shock 3:403, 1995.
39.
Tirosh A, Rudich A, Bashan N: Regulation of glucose
transporters—implications for insulin resistance states. J Pediatr Endocrinol
13:115, 2000.
40.
Lang CH, Dobrescu C: In vivo insulin resistance
during nonlethal hypermetabolic sepsis. Circ Shock 28:165, 1989.
41.
Lang CH, Dobrescu C: Gram-negative infection increases
non-insulin-mediated glucose disposal. Endocrinology 128:645, 1991.
42.
Vary TC, Siegel JH, Nakatani T, et al: Effects
of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver.
Am J Physiol 250:E634, 1986.
43.
Vary TC, Siegel JH, Tall D, et al: Role of anaerobic
bacteria in intraabdominal septic abscess in mediating septic control of skeletal
muscle glucose oxidation and lactic acidosis. J Trauma 29:1003, 1989.
44.
Nanni G, Siegel JH, Coleman B, et al: Increased
lipid fuel dependence in the critically ill septic patient. J Trauma 24:14, 1984.
45.
Sganga G, Siegel JH, Coleman B, et al: The physiologic
meaning of respiratory index in various types of critical illness. Circ Shock 17:179,
1985.
46.
Stoner HB, Little RA, Frayn KN, et al: The effect
of sepsis on the oxidation of carbohydrate and fat. Br J Surg 70:32, 1983.
47.
Vary TC: Sepsis-induced alterations in pyruvate
dehydrogenase activity in rat skeletal muscles: Effect on plasma lactate. Shock
6:89, 1996.
48.
Vary TC, Siegel JH, Tall BD, et al: Metabolic
effect of partial reversal of pyruvate dehydrogenase activity by dichloroacetate
in sepsis. Circ Shock 24:3, 1988.
49.
Vary TC, Siegel JH, Zechnich A, et al: Pharmacological
reversal of abnormal glucose regulation, BCAA utilization and muscle catabolism in
sepsis by dichloroacetate. J Trauma 28:1301, 1988.
50.
Vary TC, Siegel JH, Placko R, et al: Effect of
dichloroacetate on plasma and hepatic amino acids in sterile inflammation and sepsis.
Arch Surg 124:1071, 1989.
51.
Vary TC, Murphy JM: Role of extra-splanchnic organs
in the metabolic response to sepsis: Effect of insulin. Circ Shock 29:41, 1989.
52.
Vary TC, Plack R, Siegel JH: Pharmacologic modulation
of increased release of gluconeogenic precursors from extra-splanchnic organs in
sepsis. Circ Shock 29:59, 1989.
53.
Long CL, Kinney JM, Geiger JW: Non-suppressibility
of gluconeogenesis by glucose in septic patients. Metabolism 25:193, 1975.
54.
Crane CW, Picou D, Smith R, et al: Protein turnover
in patients before and after elective orthopedic operations. Br J Surg 64:129, 1977.
55.
Wernerman J, von der Decken A, Vinnars E: Protein
synthesis in skeletal muscle in relation to nitrogen balance after abdominal surgery:
The effect of total parenteral nutrition. JPEN J Parenter Enteral Nutr 10:578,
1986.
56.
Long CL, Birkhahn RH, Geiger JW, et al: Urinary
excretion of 3-methylhistidine: An assessment of muscle protein catabolism in adult
normal subjects and during malnutrition, sepsis and skeletal trauma. Metabolism
30:765, 1981.
57.
Rennie MJ, Bennegard K, Eden E, et al: Urinary
excretion and efflux from the leg of 3-methylhistidine before and after major surgical
operation. Metabolism 33:250, 1984.
58.
Rennie MJ: Muscle protein turnover and the wasting
due to injury and disease. Br Med Bull 41:257, 1985.
59.
Rennie MJ, Edwards RHT, Emery PW, et al: Depressed
protein synthesis is the dominant characteristic of muscle wasting and cachexia.
Clin Physiol 3:387, 1983.
60.
Clowes GHA, George BC, Villee C, et al: Muscle
proteolysis induced by a circulating peptide in patients with sepsis and trauma.
N Engl J Med 308:545, 1983.
61.
Vary TC: Regulation of skeletal muscle protein
turnover during sepsis. Curr Opin Nutr Metab Care 1:217, 1998.
62.
Jepson MM, Pell JM, Bates PC, et al: The effects
of endotoxaemia on protein metabolism in skeletal muscle and liver of fed and fasted
rats. Biochem J 235:329, 1986.
63.
Vinnars E, Bergstrom J, Furst P: Influence of
postoperative state in the intracellular free amino acids in human muscle tissue.
Ann Surg 163:665, 1975.
64.
Askanazi J, Carpenter YA, Michelsen CB, et al:
Muscle and plasma amino acids following injury. Ann Surg 192:78, 1980.
65.
MacLennon PA, Brown RA, Rennie MJ: A positive
relationship between protein synthetic rate and intracellular glutamine concentration
in perfused rat skeletal muscle. FEBS Lett 215:187, 1987.
66.
Albina JE, Henry W, King PA, et al: Glutamine
metabolism in rat skeletal muscle wounded with L-carrageenan. Am J Physiol 252:E49,
1987.
67.
Wilmore DW, Rombeau JL: Glutamine metabolism:
Nutritional and clinical significance. J Nutr 131:24475, 2001.
68.
Stehle P, Zander J, Mertes N, et al: Effect of
parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance
after major surgery. Lancet 1:231, 1989.
69.
Wernerman J, Hammarkvist K, Ali MR, et al: Glutamine
and ornithine-ketoglutarate but not branched chain amino acids reduce the loss of
glutamine after surgical trauma. Metabolism 38(Suppl 1):63, 1989.
70.
Wilmore DW, Aulick LH, Mason AP, et al: Influence
of burn wound on local and systemic response to injury. Ann Surg 186:444, 1977.
71.
Rannels SR, Jefferson LS: Effects of glucocorticoid
on muscle protein turnover in perfused rat hemicorpus. Am J Physiol 238:E564, 1980.
72.
Li JB, Jefferson LS: Effect of isoproterenol on
amino acid levels and protein turnover in skeletal muscle. Am J Physiol 232:E243,
1977.
73.
Hasselgren P-O, Fischer JE: Regulation by insulin
of muscle protein metabolism during sepsis and other catabolic conditions. Nutrition
8:434, 1992.
74.
Jefferson LS, Vary TC, Kimball SR: Regulation
of protein metabolism in muscle. In Jefferson LS,
Cherrington AD (eds): Handbook of Endocrinology. II. The Endocrine Pancreas and
Regulation of Metabolism. Bethesda, MD, American Physiology Society, 2001, pp 529–552.
75.
Wilmore, DW: Catabolic illness—Strategies
for enhancing recovery. N Engl J Med 325:695, 1991.
76.
Dahn, MS, Lange MP, Jacobs LA: Insulin-like growth
factor-1 production is inhibited in human sepsis. Arch Surg 123:1409, 1988.
77.
Ross RJ, Miell JP, Freeman E, et al: Critically
ill patients have high basal growth hormone levels with attenuated oscillatory activity
associated with low levels of insulin-like growth factor-I. Clin Endocrinol 35:47,
1991.
78.
Takala J, Ruokonen E, Webster NR, et al: Increased
mortality associated with growth hormone treatment in critically ill adults. N Engl
J Med 341:785, 1999.
79.
Gulve EA, Dice JF: Regulation of protein synthesis
and degradation in L8 myotubes: Effects of serum, insulin, and insulin-like-growth
factors. Biochem J 260:377, 1989.
80.
Fuller S J, Mynett JR, Sugden PH: Stimulation
of cardiac protein synthesis by insulin-like growth factors. Biochem J 282:85, 1992.
81.
Fryburg DA: Insulin-like growth factor 1 exerts
growth hormone- and insulin-like actions on human muscle protein metabolism. Am
J Physiol Endocrinol Metab 267:E331, 1994.
82.
Russell-Jones DL, Umpleby A, Hennessey T, et al:
Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis
in normal humans. Am J Physiol Endocrinol Metab 267:E591, 1994.
83.
Svanberg E, Zachrisson H, Ohlsson C, et al: Role
of insulin and IGF-I in activation of muscle protein synthesis after oral feeding.
Am J Physiol Endocrinol Metab 270:E614, 1996.
84.
Bark TH, McNurlan MA, Lang CH, Garlick PJ: Increased
protein synthesis after acute IGF-I or insulin infusion is localized to muscle in
mice. Am J Physiol Endocrinol Metab 275:E118, 1998.
85.
O'Sullivan U, Gluckman PD, Breier BH, et al: Insulin-like
growth factor I (IGF-I) reduces weight loss in mice during starvation. Endocrinology
125:2793, 1989.
86.
Lieberman SA, Butterfield GE, Harrison D, Hoffman
AR: Anabolic effects of recombinant insulin-like growth factor-I in cachetic patients
with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 78:404, 1994.
87.
Tomas FM, Knowles SE, Owens PC, et al: Increased
weight gain, nitrogen retention, and muscle protein synthesis following treatment
of diabetic rats with insulin-like growth factor (IGF)-I and des(1–3) IGF-I.
Biochem J 276:547, 1991.
88.
Dardevet D, Sornet C, Savary I, et al: Glucocoticoid
effects on insulin- and IGF-I—regulated muscle protein metabolism during aging.
J Endocrinol 156:83, 1998.
89.
Tomas FM, Knowles SE, Owens PC, et al: Insulin-like
growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated
rats. Biochem J 282:91, 1992.
90.
Herndon D, Ramzy P, DebRoy M, et al: Muscle protein
catabolism after severe burn: Effects of IGF-1/IGFBP-3 treatment. Ann Surg 229:713,
1999.
91.
Dickerson RN, Manzo CB, Charland SL, et al: The
effects of insulin-like growth factor-1 on protein metabolism and hepatic response
to endotoxin in parenterally fed rats. J Surg Res 58:260, 1995.
92.
Lang CH, Fan J, Cooney R, Vary TC: IL-1 receptor
antagonist attenuates sepsis-induced alterations in IGF system and protein synthesis.
Am J Physiol Endocrinol Metab 270:E430, 1996.
93.
Jurasinski CV, Vary TC: Insulin-like growth factor-I
accelerates protein synthesis during sepsis. Am J Physiol Endocrinol Metab 269:E977,
1995.
94.
Vary T, Dardevet D, Grizard J, et al: Differential
regulation of skeletal muscle protein turnover by insulin and IGF-I following bacteremia.
Am J Physiol Endocrinol Metab 275:E584, 1998.
95.
Hobler S, Williams A, Fischer JE, Hasselgren PO:
IGF-I stimulates protein synthesis but does not inhibit protein breakdown in muscle
from septic rats. Am J Physiol Reg Int Comp Physiol 274:R571, 1998.
96.
Svanberg E, Frost RA, Lang CH, et al: IGF-I/IGFBP-3
binary complex modulates sepsis induced inhibition of protein synthesis in skeletal
muscle. Am J Physiol Endocrinol Metab 279:E1145, 2000.
97.
Fan J, Bagby GJ, Gelato MC, Lang CH: Regulation
of insulin-like growth factor-I content and IGF-binding proteins by tumor necrosis
factor. Am J Physiol Reg Int Comp Physiol 269:R1204, 1995.
98.
Fan J, Molina PE, Gelato MC, Lang CH: Differential
tissue regulation of insulin-like growth factor-I content and binding proteins after
endotoxin. Endocrinology 134:1685, 1994.
99.
Lang CH, Fan J, Cooney R, Vary TC: IL-1 receptor
antagonist attenuates sepsis-induced alterations in IGF system and protein synthesis.
Am J Physiol Endocrinol Metab 270:E430, 1996.
100.
Fedele MJ, Vary TC, Farrell PA: IGF-I antibody
prevents increases in protein synthesis in epitrochlearis muscles from refed, diabetic
rats. J Appl Physiol 90:1166, 2001.
101.
Lang CH, Fan J, Cooney R, Vary TC: IL-1 receptor
antagonist attenuates sepsis-induced alterations in IGF system and protein synthesis.
Am J Physiol Endocrinol Metab 270:E430, 1996.
102.
Vary TC, Dardevet D, Voisin L, et al: Pentoxifylline
improves insulin action limiting skeletal muscle catabolism following infection.
J Endocrinol 163:15, 1999.
103.
Cooney RN, Kimball SR, Eckman R, et al: TNF-binding
protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis.
Am J Physiol Endocrinol Metab 276:E611, 1999.
104.
Cooney RN, Maish GO III, Gilpin T, et al: Mechanism
of IL-1 induced inhibition of protein synthesis in skeletal muscle. Shock 11:235,
1999.
105.
Cooney R, Owens E, Jurasinski C, et al: Interleukin-1
receptor antagonist prevents sepsis-induced inhibition of protein synthesis. Am
J Physiol Endocrinol Metab 267:E636, 1994.
106.
Cooney R, Pantaloni A, Sarson Y, Vary T: A pilot
study on the metabolic effects of IL-1ra in patients with severe sepsis. In
Mondozzi S (ed): 4th International Congress on Immune Consequences of Trauma, Shock,
and Sepsis, Bologna, Italy, 1997, p 909.
107.
Bower RH, Muggia-Sullan M, Vallgren S, et al:
Branched chain amino acid-enriched solutions in septic patients. Ann Surg 203:13,
1986.
108.
Garcia-de-Lorenzo P, Ortiz-Leybu C, et al: Parenteral
administration of different amounts of branched-chain amino acids in septic patients:
Clinical and metabolic effects. Crit Care Med 25:418, 1992.
109.
Freund HR, Ryan JA, Fischer JE: Amino acid derangements
in patients with sepsis: Treatment with branched chain amino acid rich effusions.
Ann Surg 188:423, 1978.
110.
Shimanura Y, Obayashi M, Murakamu T, Harris RA:
Regulation of branched-chain amino acid catabolism: Nutritional and hormonal regulation
of activity and expression of the branched-chain alpha-ketoacid dehydrogenase kinase.
Curr Opin Clin Nutr Metab Care 4:419, 2001.
111.
Ichihara K, Neely JR, Siehl DL, et al: Utilization
of leucine by working rat heart. Am J Physiol 239:E430, 1980.
112.
Buse MG, Atwell R, Mancusi V: In vitro effect
by branched chain amino acids on the ribosomal cycles in muscles of fasted rats.
Horm Metab Res 11:289, 1979.
113.
Vary TC, Jefferson LS, Kimball SR: Amino acids-induced
stimulation of translation initiation in rat skeletal muscle. Am J Physiol Endocrine
Metab 272:E-1072, 1999.
114.
Vary TC, Kimball SR: Regulation of hepatic protein
synthesis in chronic inflammation and sepsis. Am J Physiol 262:C445, 1992.
115.
Sganga G, Siegel JH, Brown G, et al: Reprioritization
of hepatic plasma protein release in trauma and sepsis. Arch Surg 120:187, 1985.
116.
Princeton GMG, Nieuwenhuizen W, Mol-Backx GPBM,
et al: Direct evidence of transcriptional control of fibrinogen and albumin synthesis
in rat liver during the acute-phase response. Biochem Biophys Res Commun 102:717,
1981.
117.
Ricca GA, Hamilton RW, McLean JW, et al: Rat
1-acid glycoprotein mRNA: Cloning of double-stranded cDNA and kinetics of induction
of mRNA levels following acute inflammation. J Biol Chem 256:10362, 1981.
118.
Schreiber G, Howlett G, Hagashima M, et al: The
acute-phase response of plasma protein synthesis during experimental inflammation.
J Biol Chem 257:10271, 1982.
119.
Liao WS, Jefferson LS, Taylor JM: Changes in
plasma albumin concentration, synthesis rate, and mRNA level during acute inflammation.
Am J Physiol Cell Physiol 251:C928, 1986.
120.
Heinrich PC, Castell JV, Andus T: Interleukin
6 and acute phase response. Biochem J 265:621, 1990.
121.
Blackham M, Cesar D, Park O-J, et al: Effects
of recombinant monokines on hepatic pyruvate dehydrogenase, pyruvate dehydrogenase
kinase, lipogenesis de novo and plasma triacylglycerols. Biochem J 284:129, 1992.
122.
Feingold KR, Soued M, Serio MK, et al: The effect
of diet on tumor necrosis stimulation of hepatic lipogenesis. Metabolism 39:623,
1990.
123.
Vary TC, Siegel JH, Nakatani T, et al: A biochemical
basis for depressed ketogenesis in sepsis. J Trauma 26:419, 1986.
124.
Black PR, Brooks BC, Bessley PQ, et al: Mechanism
of insulin resistance following injury. Ann Surg 196:420, 1982.
125.
Jurasinski C, Gray K, Vary TC: Modulation of
skeletal muscle protein synthesis by amino acids and insulin during sepsis. Metabolism
44:1130, 1995.
126.
Vary TC, Jefferson LS, Kimball SR: Insulin fails
to stimulate muscle protein synthesis in sepsis despite unimpaired signaling to 4E-BP1
and S6K1. Am J Physiol Endocrinol Metab 281:E1045, 2001.
127.
Kinney JM: The application of indirect calorimetry
to clinical studies. In Kinney JM (ed): Assessment
of Energy Metabolism in Health and Disease. Columbus, Ohio, Ross Laboratories, 1980,
p 42.
128.
Dudrick SJ: Parenteral nutrition. In
Dudrick SJ, Baue AE, Eiseman B, et al (eds): Manual of Preoperative and Postoperative
Care. Philadelphia, WB Saunders, 1983, p 86.
129.
Antonas KN, Curtas MS, Meguid MM: Use of serum
CPK-MM to monitor response to nutritional intervention in catabolic surgical patients.
J Surg Res 42:219, 1987.
130.
Elwyn DH, Kinney JM: A unique approach to measuring
total energy expenditure by indirect calorimetry. In
Kinney JM (ed): Assessment of Energy Metabolism in Health and Disease. Columbus,
Ohio, Ross Laboratories, 1980, p 54.
131.
Van Lanschot JJB, Feenstra BWA, Looijen R, et
al: Total parenteral nutrition in critically ill surgical patients: Fixed vs tailored
caloric replacement. Intensive Care Med 13:46, 1987.
132.
Keys A, Taylor HL, Grande F: Basal metabolism
and age of adult man. Metabolism 22:579, 1973.
133.
Biebuyck JF: Total parenteral nutrition in the
perioperative period: A time for caution? Anesthesiology 54:360, 1981.
134.
Bistrian BR, Bothe A Jr, Blackburn GL: Complications
of total parenteral nutrition. Clin Anaesthesiol 1:693, 1983.
135.
Grimble GK, Payne-James JJ, Silk DBA: Advances
in nutrition in the critically ill. Baillieres Clin Anaesthesiol 6:213, 1992.
136.
Weir JBV: New methods for calculating metabolic
rate with special reference to protein metabolism. J Physiol (Lond) 109:1, 1949.
137.
Frayn KN: Calculation of substrate oxidation
rate in vivo from gaseous exchange. J Appl Physiol 55:628, 1983.
138.
Lowry SF, Horowitz GD, Brennan MF: Body protein
kinetics during perioperative intravenous nutritional support. Surg Gynecol Obstet
163:303, 1986.
139.
Elwyn DH, Kinney JM, Jeevanandam M, et al: Influence
of increasing carbohydrate intake on glucose kinetics in injured man. Ann Surg 191:117,
1979.
140.
Brennan MF, Horowitz GD: Total parenteral nutrition
in surgical patients. Adv Surg 17:1, 1984.
141.
Quandt CM, Horst HM, Obeid FN, et al: Accuracy
of two-hour urine urea nitrogen determinations in critically ill patients. Clin
Pharm 3:408, 1984.
142.
Wilmore DW: The Metabolic Management of the Critically
Ill. New York, Plenum, 1977.
143.
Kinney JM, Morgan AP, Domingues FJ, et al: A
method for continuous measurement of gas exchange and expired radioactivity in acutely
ill patients. Metabolism 13:205, 1964.
144.
Damask MC, Forse RA, Kinney JM: Clinical applications
of gas exchange measurements. Clin Anaesthesiol 1:599, 1983.
145.
Bursztein S, Elwyn DH, Apleanazi J, et al: Energy
Metabolism, Indirect Calorimetry, and Nutrition. Baltimore, Williams & Wilkins,
1989.
146.
Adams S, Dellinger EP, Wertz MJ, et al: Enteral
versus parenteral nutritional support following laparotomy for trauma: A randomized
prospective trial. J Trauma 26:882, 1986.
147.
Moore EE, Jones TN: Benefits of immediate jejunostomy
feeding after major abdominal trauma: A prospective, randomized study. J Trauma
26:874, 1986.
148.
Fong Y, Macano MA, Barber A, et al: Total parenteral
nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann
Surg 210:449, 1989.
149.
Chang RWS, Jacobs S, Lee B: Gastrointestinal
dysfunction among intensive care unit patients. Crit Care Med 15:909, 1987.
150.
Aldin PB, Svingen BA, Johnson SB, et al: Partial
correction by exogenous lipid of abnormal patterns of polyunsaturated fatty acids
in plasma phospholipids of stressed and septic surgical patients. Surgery 100:671,
1986.
